Board of Directors

Dr. Marcia Eisenberg

Dr. Marcia Eisenberg, chief scientific officer, Labcorp Diagnostics has extensive experience with forensic DNA testing, biotechnology, molecular genetics and molecular oncology. She has helped lead the development and validation of well over a thousand clinical assays used for patient care during her more than 30-year tenure at Labcorp (NYSE: LH), a global life sciences company. Dr. Eisenberg previously held roles on the National Institute of Environmental Health Sciences and the FBI’s National DNA Advisory Board, where she was later recognized for her contributions to the advancement of DNA technology.   A molecular biologist by training, Dr. Eisenberg was a member of the team responsible for commercializing polymerase chain reaction (PCR) tests in the 1990s, making large-scale testing possible. Over the last year, she has led the effort at Labcorp and across the industry to use that same technology to make high-quality testing for COVID-19 broadly available. She is highly regarded within the industry and has been instrumental in developing innovations in diagnostics and patient care, improving the health and lives of people around the globe. Dr. Eisenberg was recently recognized by the Healthcare Businesswomen’s Association (HBA) as a 2021 Luminary. She serves as a member of the board of directors of Singular Genomics Systems, Inc. (Nasdaq: OMIC) based in San Diego, CA. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing and multiomics technologies.

Dr. Eisenberg received bachelor’s degrees in biology and psychology from SUNY Albany, a master’s degree in molecular biology from SUNY Albany and a PhD in molecular biology from the University of Kentucky.